Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Eutravac (DTaP-HB) in Healthy Infants
NCT01896739Phase 3Completed
- Sponsor
- LG Chem
- Start
- Aug 2009
- Primary completion
- Nov 2011
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Eutravac in diphtheria, Tetanus, pertussis, hepatitis B (HBV), sponsored by LG Chem. Started Aug 2009; status: completed.
02
Drugs
Eutravac
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)
Beyond the preview
Go deeper on NCT01896739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01896739.